Erik Labergerie, an accomplished inventor based in Armentieres, France, has made significant strides in the field of pharmaceuticals with his innovative contributions. Holding six patents, Labergerie's work showcases his commitment to enhancing pharmaceutical formulations and excipients.

Latest Patents

Labergerie's latest patents exemplify his expertise in developing advanced pharmaceutical materials. One of his notable inventions is the "Pulverulent Mannitol and Process for Preparing It." This patent details a pulverulent form of mannitol characterized by a specific average diameter and packed density, making it particularly suitable as an excipient for filling hard capsules in the pharmaceutical industry.

Another important patent is the "Dextrose in Powder Form and a Process for the Preparation Thereof." This invention concerns a highly pure dextrose powder with specific characteristics, suitable for use as a sweetener or excipient in both food and pharmaceutical compositions. The innovation promotes enhanced usability in the preparation of confectionery and chewable tablets, among other applications.

Career Highlights

Erik Labergerie is currently affiliated with Roquette Frères, a leader in the starch and food ingredients sector. His role in the company has allowed him to further explore and develop vital innovations in the pharmaceutical field. Through his career, Labergerie has consistently focused on creating solutions that advance product formulations and enhance user experience.

Collaborations

Throughout his career, Labergerie has worked alongside esteemed colleagues such as Philippe Lefevre and José Lis. These collaborations have not only enriched his own work but have also contributed to the overall innovation landscape within their field.

Conclusion

Erik Labergerie's contributions to the pharmaceutical sector through his innovative patents are commendable. With six patents to his name, he continues to push the boundaries of what is possible in pharmaceutical formulations, making a valuable impact on both science and industry. His work exemplifies the spirit of innovation, particularly in excipient development, ensuring that the pharmaceutical needs of the future are met with excellence.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to [email protected]